The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Dr. Van Tine Discusses the Development of Olaratumab in Sarcoma

Brian Van Tine, MD, PhD
Published Online:8:46 PM, Wed December 6, 2017

Brian Van Tine, MD, PhD, assistant professor, Washington University School of Medicine, discusses the development of olaratumab (Lartruvo) in soft tissue sarcoma.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.